P. Abdayem
Impact in
-
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 3
- Peptidase Inhibition and Analysis 3
- Cancer Treatment and Pharmacology 2
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- David Planchard (12 shared papers)Mariona Riudavets (2 shared papers)Ivana Sullivan (1 shared paper)Alex A. Adjei (1 shared paper)Aakash Desai (1 shared paper)Assaad Kesrouani (2 shared papers)Georges Abi Tayeh (1 shared paper)Fabrice Barlési (5 shared papers)
In The Last Decade
P. Abdayem
18 papers receiving 279 citations
Peers
Comparison fields: 5 of 51
- Oncology 145
- Pulmonary and Respiratory Medicine 121
- Cancer Research 31
- Radiology, Nuclear Medicine and Imaging 46
- Molecular Biology 61
Countries citing papers authored by P. Abdayem
This map shows the geographic impact of P. Abdayem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Abdayem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Abdayem more than expected).
Fields of papers citing papers by P. Abdayem
This network shows the impact of papers produced by P. Abdayem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Abdayem. The network helps show where P. Abdayem may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Abdayem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 133 | |
| 2 | 2021 | 61 | |
| 3 | 2016 | 20 | |
| 4 | 2018 | 13 | |
| 5 | 2024 | 10 | |
| 6 | Ongoing progress in BRAF-mutated non-small cell lung cancer. | 2022 | 10 |
| 7 | 2021 | 8 | |
| 8 | 2021 | 6 | |
| 9 | 2014 | 4 | |
| 10 | 2021 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2025 | 2 | |
| 14 | 2023 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2021 | 0 | |
| 20 | 2025 | 0 |
About P. Abdayem
P. Abdayem is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Molecular Biology and Cancer Research, having authored 22 papers that have together received 281 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers), Peptidase Inhibition and Analysis (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), Chromatin Remodeling and Cancer (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Oncology (145 citations), Pulmonary and Respiratory Medicine (121 citations), Cancer Research (31 citations), Radiology, Nuclear Medicine and Imaging (46 citations) and Molecular Biology (61 citations). P. Abdayem has collaborated with scholars based in France, Lebanon and Italy. Frequent co-authors include David Planchard, Mariona Riudavets, Ivana Sullivan, Alex A. Adjei, Aakash Desai, Assaad Kesrouani, Georges Abi Tayeh, Fabrice Barlési, Elie Nemr and Benjamin Besse. Their work appears in journals such as Annals of Oncology, ESMO Open, Reproductive Health, Molecular Cancer and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.